Company news
Bayer Ag (XETR:BAYN) news
Every Bayer Ag press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Bayer Launches Nationwide Science Delivers Tour to Take Science on the Road
September 10, 2026
U.S. FDA Grants Accelerated Approval to Bayer’s HYRNUO® (sevabertinib) as a First-Line Targeted Therapy for Patients with HER2-Mutated No...
September 9, 2026
Bayer and Neste Close Commercial Agreement to Jointly Scale newgold® Winter Canola for Biofuels Production
September 9, 2026
BAYER INITIATES PHASE II STUDY OF INVESTIGATIONAL GIRK4 INHIBITOR IN PATIENTS WITH ATRIAL FIBRILLATION
September 9, 2026
Bayer : initiates Phase II study of investigational GIRK4 inhibitor in patients with atrial fibrillation
September 9, 2026
First licensed treatment now available for condition behind the UK’s leading cause of horse euthanasia
September 8, 2026
Bayer Advances Combined Seed and Crop Protection Pipeline and Enters Phase of Blockbuster Launches
September 3, 2026
Bayer : Finerenone slowed kidney function decline and reduced kidney-cardiovascular risk versus placebo in patients with hypertensive nep...
August 31, 2026
Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026
August 30, 2026
Bayer : sevabertinib approved in Japan for patients with HER2-mutant non-small cell lung cancer
August 24, 2026
Bayer to Present New Phase III Data from Its Cardiovascular, Kidney, and Stroke Clinical Trial Programs at ESC 2026
August 20, 2026
Bayer : Aflibercept 8 mg application for macular edema following retinal vein occlusion accepted for review in China
August 13, 2026
Bayer : operationally on track, decisive progress on strategic priorities
August 4, 2026
Bayer : submits application for next indication of Kerendia in China
July 30, 2026
New Economist Enterprise Research Highlights Why Integrating Self-Care Into Health Systems Matters
July 23, 2026
Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials
July 17, 2026
European Commission approves JASCAYD®, bringing well-tolerated, novel oral treatment for IPF and PPF to the EU
July 17, 2026
Bayer : signs licensing agreement with RAGT and begins broad hybrid wheat commercialization by early 2030s
July 15, 2026
Bayer : Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming
July 14, 2026
Bayer Aktiengesellschaft: Bayer secures 3.0 billion euros to improve capital structure
July 10, 2026
The University of Colorado Anschutz, along with UCHealth and Children’s Hospital Colorado, Form Strategic Alliance with Bayer to Advance ...
July 7, 2026
The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado, Form Strategic Alliance with Bayer to Advance ...
July 7, 2026
Bayer Group to Consolidate U.S. Glyphosate Business Into Distinct Entity Operating as Ruveon
July 1, 2026
Bayer Welcomes Kacy Perry as New Country Division Head for Crop Science Canada
June 18, 2026
Bayer : Federal judge remands Monsanto class settlement case back to Missouri State Court
June 17, 2026
Natur Tec India and Bayer to Develop Compostable Seedling Cups
June 16, 2026
Bayer : low-dose MRI contrast agent approved in U.S.
June 15, 2026
Bayer’s AMBELVIST® (gadoquatrane) Receives FDA Approval for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vasculari...
June 15, 2026
Bayer : European Medicines Agency confirms asundexian marketing authorization application for assessment in secondary prevention of ische...
June 10, 2026
Bayer : Announces Advancement in Cardiovascular Health Assessment with Saudi Heart Association's recent publication on Early Detection of...
June 9, 2026
Bayer Announces Global Consumer Health Leadership Changes to Accelerate Growth
June 8, 2026
Bayer : finerenone significantly reduced kidney function decline and a composite of cardiovascular-kidney outcomes versus placebo in pati...
June 5, 2026
Bayer to Present First Full FIND-CKD Results Investigating KERENDIA® (finerenone) in Non-Diabetic Chronic Kidney Disease at ERA 2026
June 2, 2026
ASCO 2026: Bayer Shares New Findings for NUBEQA® (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared...
May 30, 2026
Bayer : Kerendia™ approved in China for new indication in adult patients with heart failure with LVEF ≥40%
May 22, 2026
Boehringer Ingelheim’s oncology portfolio shows strong promise across multiple cancers at ASCO 2026
May 21, 2026
ASCO 2026: Bayer to Present New Data Across Oncology Portfolio
May 21, 2026
Bayer’s KERENDIA® (finerenone) Granted Priority Review of Supplemental New Drug Application by U.S. FDA for Treatment of Adults with Type...
May 21, 2026
Bayer Granted Priority Review by U.S. FDA for Asundexian in Patients After a Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack
May 19, 2026
Bayer : FDA grants sevabertinib Priority Review as a first-line treatment for patients with HER2-mutant non-small cell lung cancer
May 18, 2026
AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Ca...
May 15, 2026
Bayer Partners with Luke Bryan to Donate 1 Million Meals Through Feeding America® to Expand Access to Food and Nutrition in Rural Communi...
May 13, 2026
Bayer : reports solid start to the year and confirms currency-adjusted Group guidance for 2026
May 12, 2026
Investigational PET Tracer Iodine 124 Evuzamitide from Bayer Met Primary Endpoints in Phase III Study in Patients Suspected to Have Cardi...
May 7, 2026
Bayer and bp Form Strategic Alliance to Jointly Scale Camelina as Intermediate Crop for Biofuels
May 6, 2026
Bayer AG Successfully Migrates to Broadridge Swift Service Bureau, Strengthening Global Payment Infrastructure
May 6, 2026
Bayer to Acquire Perfuse Therapeutics to Complement Ophthalmology Pipeline
May 6, 2026
Bayer to Present 13 Abstracts From Its Stroke Franchise at ESOC 2026, Including Two Late-breaking Analyses From the Phase III OCEANIC-STR...
April 29, 2026
AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s D...
April 20, 2026
Bayer Canada Supports New School of Medicine at Simon Fraser University (SFU) With Full Tuition Entrance Award for Inaugural Class
April 15, 2026